on GENSIGHT BIOLOGICS S.A. (EPA:SIGHT)
Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares
Delaware-based The Goldman Sachs Group, Inc. has crossed the 5% equity and voting rights thresholds of GENSIGHT BIOLOGICS SA, according to a statement received on September 13, 2024. This crossing occurred on August 27, 2024. 2024.
According to the press release, this decline is the result of a sale of GENSIGHT BIOLOGICS SA shares off-market. This movement complies with Article 223-13 I, 2° of the general regulations, implying a trading exemption.
As a result, The Goldman Sachs Group, Inc. no longer owns GENSIGHT BIOLOGICS SA securities. Additionally, Goldman Sachs International also crossed the thresholds downward on an individual basis.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENSIGHT BIOLOGICS S.A. news